Coastlands Capital LP - 14 Jul 2026 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Reporting relationship: 10%+ Owner
Issuer ticker: ADIL
Reported as of: 14 Jul 2026
Net transaction value: +$8,691
SEC form: 4
Accepted by SEC: 16 Jul 2026, 17:08:32 UTC
Prior SEC filing: 13 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP

Key filing fact

Coastlands Capital LP filed Form 4 for ADIAL PHARMACEUTICALS, INC. (ADIL) on 16 Jul 2026.

Key facts

This page summarizes Coastlands Capital LP's Form 4 filing for ADIAL PHARMACEUTICALS, INC. (ADIL).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 16 Jul 2026, 17:08.

Change

Previous filing in this sequence was filed on 13 Jul 2026.
Current net transaction value: +$8,691.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002068530 Primary reporting owner

Coastlands Capital LP

Relationship: 10%+ Owner
Address: 601 CALIFORNIA STREET, SUITE 1210, SAN FRANCISCO
Signature: /s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP
Signature date: 16 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADIL transaction

Common Stock

Purchase

Transaction value: $5,300
Shares: +2,000
Change %: +0.52%
Price: $2.65
Shares after: 387,075
Date: 14 Jul 2026
Ownership: By Coastlands Capital LP
Footnotes: F1

ADIL transaction

Common Stock

Purchase

Transaction value: $3,391
Shares: +1,233
Change %: +0.32%
Price: $2.75
Shares after: 388,308
Date: 16 Jul 2026
Ownership: By Coastlands Capital LP
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.